Table 1.
Initial cohort characteristics
| Overall population | n=417 | % |
| Sex F/M, n (%) | 221 | 53 |
| Age, years (median (IC)) | 65, (63–67) | |
| Arterial hypertension, n (%) | 179 | 43 |
| Obesity, n (%) | 74 | 18 |
| Dyslipidaemia, n (%) | 109 | 26 |
| Diabetes, n (%) | 55 | 13 |
| Smoking, n (%) | 110 | 26 |
| History of stroke, n (%) | 26 | 6 |
| Inflammatory disease, n (%) | 33 | 8 |
| Psychiatric pathology, n (%) | 83 | 20 |
| Provoked, n (%) | 212 | 51 |
| Associated DVT, n (%) | 186 | 45 |
| Proximal DVT | 92 | 22 |
| Distal DVT | 94 | 23 |
| Thrombolysis, n (%) | 21 | 5 |
| Aspirin treatment | 68 | 16.3 |
| Statin treatment | 42 | 10 |
| Psychotropic medication | 76 | 18.2 |
| Duration of hospital stay, days (median (IC)) | 5 (4–5) | |
| Initial anticoagulation duration, months (median (IC)) | 6 (6–6) | |
| Follow-up period, months (median (IC)) | 36 (33–40) | |
| VTE recurrence, n (%) | 72 | 18 |
| PE, n (% of recurrence) | 63 | 88 |
| DVT, n (% of recurrence) | 9 | 12 |
| Time to recurrence, in months, (median, (IC)) | 18.5 (14–24) |
DVT, deep vein thrombosis; PE, pulmonary embolism; VTE, venous thromboembolism.